A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial

David Erritzoe, Tommaso Barba, Tiffanie Benway, Zelah Joel, Meghan Good, Marie Layzell, Michelle Baker Jones, Graham Campbell, Ashleigh Murphy-Beiner, Peter Rands, Malcolm Boyce, Helen Topping, Brandon Weiss, Christopher Timmermann, David Nutt, Robin Carhart-Harris, Carol Routledge, Ellen James

Open source

DOI
10.1038/s41591-025-04154-z
Published
2026-02
Container
Nature Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-025-04154-z,
  title = {A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial},
  author = {David Erritzoe and Tommaso Barba and Tiffanie Benway and Zelah Joel and Meghan Good and Marie Layzell and Michelle Baker Jones and Graham Campbell and Ashleigh Murphy-Beiner and Peter Rands and Malcolm Boyce and Helen Topping and Brandon Weiss and Christopher Timmermann and David Nutt and Robin Carhart-Harris and Carol Routledge and Ellen James},
  year = {2026},
  journal = {Nature Medicine},
  doi = {10.1038/s41591-025-04154-z},
  url = {https://doi.org/10.1038/s41591-025-04154-z}
}

RIS

TY  - JOUR
TI  - A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial
AU  - David Erritzoe
AU  - Tommaso Barba
AU  - Tiffanie Benway
AU  - Zelah Joel
AU  - Meghan Good
AU  - Marie Layzell
AU  - Michelle Baker Jones
AU  - Graham Campbell
AU  - Ashleigh Murphy-Beiner
AU  - Peter Rands
AU  - Malcolm Boyce
AU  - Helen Topping
AU  - Brandon Weiss
AU  - Christopher Timmermann
AU  - David Nutt
AU  - Robin Carhart-Harris
AU  - Carol Routledge
AU  - Ellen James
PY  - 2026
JO  - Nature Medicine
DO  - 10.1038/s41591-025-04154-z
UR  - https://doi.org/10.1038/s41591-025-04154-z
ER  - 

APA

Erritzoe, D., Barba, T., Benway, T., Joel, Z., Good, M., Layzell, M., Jones, M. B., Campbell, G., Murphy-Beiner, A., Rands, P., Boyce, M., Topping, H., Weiss, B., Timmermann, C., Nutt, D., Carhart-Harris, R., Routledge, C., & James, E. (2026). A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial. Nature Medicine. https://doi.org/10.1038/s41591-025-04154-z

Source records